We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688012:SSEAdvanced Micro-Fabrication Equipment Inc. China Class A Analysis

Data as of 2026-03-15 - not real-time

CN¥312.93

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Advanced Micro-Fabrication Equipment is trading at CNY 312.93, hovering just above the computed support of CNY 309.07 and well below its 20‑day SMA of CNY 341.05, indicating a potential price floor. The RSI of 36.7 points to a mildly oversold condition, while the MACD histogram remains negative, suggesting short‑term bearish momentum despite an overall bullish trend direction. Volatility is elevated at 43.5% over the past 30 days, yet the beta is exceptionally low (≈0.07), implying limited systematic risk. Fundamentally, the company posted 21.5% revenue growth and a healthy operating margin of 31.8%, but its trailing PE of 101.9x dwarfs the industry average of 33.7x, marking it as significantly overvalued. Cash holdings of CNY 8.3 bn dwarf the modest debt load of CNY 0.76 bn, and the dividend payout ratio sits under 10%, supporting dividend sustainability. The semiconductor equipment sector remains cyclical and policy‑sensitive, with Chinese government backing for domestic chip production, which could underpin medium‑ to long‑term demand. However, the current valuation premium and mixed technical signals advise caution in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support
  • Negative MACD histogram
  • Oversold RSI

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth
  • High valuation relative to peers
  • Robust cash position

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • China's semiconductor self‑sufficiency drive
  • Expanding product portfolio in etch and MOCVD equipment
  • Sustainable dividend with low payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth21.50%
Profit Margin17.05%
P/E Ratio101.9
ROE10.26%
Debt/Equity3.54
P/B Ratio9.1
Industry P/E33.7

Technical Analysis

TrendBullish
RSI36.7
SupportCN¥309.07
ResistanceCN¥376.22
MA 20CN¥341.05
MA 50CN¥338.42
MA 200CN¥255.90
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

GradeOvervalued
TypeBlend
Dividend Yield0.10%

Risk Assessment

Beta0.07
Volatility43.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.